|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leong TY and Leong AS: Epidemiology and
carcinogenesis of hepatocellular carcinoma. HPB (Oxford). 7:5–15.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Buendia MA and Neuveut C: Hepatocellular
carcinoma. Cold Spring Harb Perspect Med. 5:a0214442015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lemmer ER, Friedman SL and Llovet JM:
Molecular diagnosis of chronic liver disease and hepatocellular
carcinoma: The potential of gene expression profiling. Semin Liver
Dis. 26:373–384. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matter MS, Decaens T, Andersen JB and
Thorgeirsson SS: Targeting the mTOR pathway in hepatocellular
carcinoma: Current state and future trends. J Hepatol. 60:855–865.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Easwaran H, Tsai HC and Baylin SB: Cancer
epigenetics: Tumor heterogeneity, plasticity of stem-like states
and drug resistance. Mol Cell. 54:716–727. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma L, Chua MS, Andrisani O and So S:
Epigenetics in hepatocellular carcinoma: An update and future
therapy perspectives. World J Gastroenterol. 20:333–345. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rydel TJ, Williams JM, Krieger E, Moshiri
F, Stallings WC, Brown SM, Pershing JC, Purcell JP and Alibhai MF:
The crystal structure, mutagenesis, and activity studies reveal
that patatin is a lipid acyl hydrolase with a Ser-Asp catalytic
dyad. Biochemistry. 42:6696–6708. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wilson PA, Gardner SD, Lambie NM, Commans
SA and Crowther DJ: Characterization of the human patatin-like
phospholipase family. J Lipid Res. 47:1940–1949. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Finn RD, Bateman A, Clements J, Coggill P,
Eberhardt RY, Eddy SR, Heger A, Hetherington K, Holm L, Mistry J,
et al: Pfam: The protein families database. Nucleic Acids Res.
42(Database Issue): D222–D230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Winrow CJ, Hemming ML, Allen DM, Quistad
GB, Casida JE and Barlow C: Loss of neuropathy target esterase in
mice links organophosphate exposure to hyperactivity. Nat Genet.
33:477–485. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kienesberger PC, Lass A, Preiss-Landl K,
Wolinski H, Kohlwein SD, Zimmermann R and Zechner R: Identification
of an insulin-regulated lysophospholipase with homology to
neuropathy target esterase. J Biol Chem. 283:5908–5917. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Herman JG and Baylin SB:
Methylation-specific PCR. Curr Protoc Hum Genet Chapter. 10:Unit
10.6. 2001. View Article : Google Scholar
|
|
15
|
Kienesberger PC, Oberer M, Lass A and
Zechner R: Mammalian patatin domain containing proteins: A family
with diverse lipolytic activities involved in multiple biological
functions. J Lipid Res. 50(Suppl): S63–S68. 2009.PubMed/NCBI
|
|
16
|
Chang PA, Long DX, Sun Q, Wang Q, Bu YQ
and Wu YJ: Identification and characterization of a splice variant
of the catalytic domain of mouse NTE-related esterase. Gene.
417:43–50. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Richardson RJ, Hein ND, Wijeyesakere SJ,
Fink JK and Makhaeva GF: Neuropathy target esterase (NTE): Overview
and future. Chem Biol Interact. 203:238–244. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang PA, Chen YY, Long DX, Qin WZ and Mou
XL: Degradation of mouse NTE-related esterase by macroautophagy and
the proteasome. Mol Biol Rep. 39:7125–7131. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kotronen A, Johansson LE, Johansson LM,
Roos C, Westerbacka J, Hamsten A, Bergholm R, Arkkila P, Arola J,
Kiviluoto T, et al: A common variant in PNPLA3, which encodes
adiponutrin, is associated with liver fat content in humans.
Diabetologia. 52:1056–1060. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sookoian S, Castaño GO, Burgueño AL,
Gianotti TF, Rosselli MS and Pirola CJ: A nonsynonymous gene
variant in the adiponutrin gene is associated with nonalcoholic
fatty liver disease severity. J Lipid Res. 50:2111–2116. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Valenti L, Al-Serri A, Daly AK, Galmozzi
E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E,
et al: Homozygosity for the patatin-like
phospholipase-3/adiponutrin I148M polymorphism influences liver
fibrosis in patients with nonalcoholic fatty liver disease.
Hepatology. 51:1209–1217. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vrieze SI, Malone SM, Pankratz N,
Vaidyanathan U, Miller MB, Kang HM, McGue M, Abecasis G and Iacono
WG: Genetic associations of nonsynonymous exonic variants with
psychophysiological endophenotypes. Psychophysiology. 51:1300–1308.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jones PA and Laird PW: Cancer epigenetics
comes of age. Nat Genet. 21:163–167. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lopez-Serra P and Esteller M: DNA
methylation-associated silencing of tumor-suppressor microRNAs in
cancer. Oncogene. 31:1609–1622. 2012. View Article : Google Scholar : PubMed/NCBI
|
